Death receptor-mediated hepatocyte apoptosis is implicated in a wide range of liver diseases including viral and alcoholic hepatitis, ischemia/reperfusion injury, fulminant hepatic failure, cholestatic liver injury, as well as cancer. Deletion of NF-jB essential modulator in hepatocytes (IKKc/Nemo) causes spontaneous progression of TNF-mediated chronic hepatitis to hepatocellular carcinoma (HCC). Thus, we analyzed the role of death receptors including TNFR1 and TRAIL in the regulation of cell death and the progression of liver injury in IKKc/Nemo-deleted livers. We crossed hepatocyte-specific IKKc/Nemo knockout mice (Nemo Dhepa ) with constitutive TNFR1 À / À and TRAIL À / À mice. Deletion of TNFR1, but not TRAIL, decreased apoptotic cell death, compensatory proliferation, liver fibrogenesis, infiltration of immune cells as well as pro-inflammatory cytokines, and indicators of tumor growth during the progression of chronic liver injury. These events were associated with diminished JNK activation. In contrast, deletion of TNFR1 in bone-marrow-derived cells promoted chronic liver injury. Our data demonstrate that TNF-and not TRAIL signaling determines the progression of IKKc/Nemo-dependent chronic hepatitis. Additionally, we show that TNFR1 in hepatocytes and immune cells have different roles in chronic liver injury-a finding that has direct implications for treating chronic liver disease.
Death receptor-mediated hepatocyte apoptosis is implicated in a wide range of liver diseases including viral and alcoholic hepatitis, ischemia/reperfusion injury, fulminant hepatic failure, cholestatic liver injury, as well as cancer. Deletion of NF-jB essential modulator in hepatocytes (IKKc/Nemo) causes spontaneous progression of TNF-mediated chronic hepatitis to hepatocellular carcinoma (HCC). Thus, we analyzed the role of death receptors including TNFR1 and TRAIL in the regulation of cell death and the progression of liver injury in IKKc/Nemo-deleted livers. We crossed hepatocyte-specific IKKc/Nemo knockout mice (Nemo Dhepa ) with constitutive TNFR1 À / À and TRAIL À / À mice. Deletion of TNFR1, but not TRAIL, decreased apoptotic cell death, compensatory proliferation, liver fibrogenesis, infiltration of immune cells as well as pro-inflammatory cytokines, and indicators of tumor growth during the progression of chronic liver injury. These events were associated with diminished JNK activation. In contrast, deletion of TNFR1 in bone-marrow-derived cells promoted chronic liver injury. Our data demonstrate that TNF-and not TRAIL signaling determines the progression of IKKc/Nemo-dependent chronic hepatitis. Additionally, we show that TNFR1 in hepatocytes and immune cells have different roles in chronic liver injury-a finding that has direct implications for treating chronic liver disease. The nuclear factor (NF)-kB signaling pathway mediates a variety of important cellular functions by regulating immune and inflammatory responses.
1,2 NF-kB transcription factors are kept inactive in the cytoplasm through binding to members of the IkB family of inhibitory proteins. Upon stimulation, NF-kB translocates into the nucleus, where it activates pro-inflammatory target genes. IKKg/Nemo is the essential regulatory unit of the IKK complex. Deletion of IKKg/Nemo is lethal during embryonic development, as mice die from hepatocyte apoptosis. [3] [4] [5] [6] [7] Futhermore, hepatocyte-specific IKKg/Nemo knockout mice (Nemo Dhepa ) are highly susceptible to TNF-mediated spontaneous cell death. 8 Recent work by our group demonstrated that apoptosis is blocked in Nemo Dhepa /Caspase8 Dhepa double knockout animals, suggesting that apoptosis is Caspase-8 (Casp8)-dependent in Nemo Dhepa mice. 9 These results implicate that death receptors have a pivotal role in the complex regulation, leading to hepatocyte apoptosis in Nemo Dhepa mice.
Among others, death receptors include TNFR1 and TRAIL receptors 1 and 2 (TRAIL-R1/DR4 and TRAIL-R2/DR5). 10 Lethal hepatocyte apoptosis observed in p65 knockout mice can be rescued by crossing these mice into a TNF or TNFR1-null background. 11, 12 However, TNFR1/p65 double-knockout mice die shortly after birth because of massive acute inflammation of the liver. Furthermore, Nemo Dhepa mice overexpress the TRAIL-specific death receptor DR5 and TRAIL-expressing NK cells are activated in Nemo Dhepa livers. 13 To specifically address the progression of TNF-mediated chronic liver injury and to define the impact of death receptormediated signaling, we questioned whether the deletion of TNFR1 or TRAIL/DR5 in a genetic model of chronic liver disease, the Nemo Dhepa mice, could have an impact on liver injury. Here, we demonstrate that the death receptor TNFR1 in hepatocytes and immune cells has different roles in the progression of liver injury in Nemo Dhepa mice.
Results
Deletion of TNFR1 decreases TNF-mediated hepato cellular damage. Hepatocytes with the deletion of IKKg/ Nemo show hypersensitivity against TRAIL and TNF. 13 
Loss of Casp8 in Nemo
Dhepa mice prevents liver apoptosis and disease progression. 9 As TNF receptor family members are upstream mediators of Casp8-dependent apoptosis, we aimed to define death receptors critically involved in mediating the function of IKKg/Nemo in cell death. Thus Figure 1c) . Our first results showed that the viability of Nemo Dhepa hepatocytes was significantly improved after TNFR1 deletion as determined by light microscopy and MTT survival assay ( Supplementary  Figures 1d and e) . Thus, we performed apoptosis-specific FACS analysis using Annexin V/FITC staining in Nemo Dhepa primary hepatocytes 8 h after plating. As controls, primary hepatocytes derived from WT and Nemo Dhepa /Casp8
Dhepa mice were included. Nemo Dhepa cells showed strong increase in Annexin V staining compared with WT hepatocytes, whereas the signal was decreased after TNFR1 deletion. Indeed, Nemo Dhepa /TNFR1 À / À , and more prominently Nemo Dhepa /Casp8 Dhepa hepatocytes, exhibited less apoptosis (Figure 1f) . Accordingly, our results suggest that TNFR1 in hepatocytes significantly contributes to apoptosis of Nemo-deficient cells.
Ablation of TNFR1 in Nemo
Dhepa liver results in reduced compensatory proliferation and liver fibrogenesis.
Chronic liver injury in Nemo
Dhepa livers triggers compensatory proliferation associated with hepatocellular carcinoma (HCC) development. 8 Therefore, we tested whether the deletion of TNFR1 or TRAIL would have an effect on cell proliferation in IKKg/Nemo-deficient livers. By using cell cycle markers for total cell cycle activity (Ki-67), S-phase progression (BrdU incorporation, Cyclin A) and G1/S-phase transition (PCNA), we found a significant decline in cell cycle activity in Nemo Dhepa /TNFR1 À / À livers. In contrast, no difference in cell proliferation was observed between Nemo Dhepa and Nemo Supplementary Figures 2A-D) .
Nemo Dhepa livers revealed increased expression of the cell cycle inhibitor p21, which is induced by liver injury or DNA damage.
14 Unexpectedly, p21 mRNA and protein expression levels were significantly decreased in Nemo Dhepa /TNFR1 Figure 3D ).
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These results demonstrate that attenuated liver injury after TNFR1 À / À deletion in Nemo Dhepa livers reduces cell infiltration and expression of pro-inflammatory cytokines.
TNFR1 triggers the activation of pro-inflammatory genes in IKKc/Nemo-deficient livers. To investigate the underlying molecular mechanisms conferring protection in Nemo Dhepa /TNFR1 À / À livers, we next performed wholeliver genome microarray to identify potential differences in target gene expression between the knockout strains compared with WT mice (Figure 4a ). Figures 4A and B) . The array analysis revealed that genes involved in mediating liver fibrosis, hepatic stellate cell activation, acute-phase response, death receptor signaling and hepatic cholestasis were significantly downregulated in Nemo Dhepa /TNFR1
mice (Supplementary
À / À compared with Nemo Dhepa and To better characterize the relevance of our findings on the activation of intracellular pathways involved in mediating the inflammatory response, we investigated the IL-6/STAT3 pathway. Concomitant with the levels of SOCS3 and SAA2, IL-6 mRNA levels were reduced in Nemo Dhepa /TNFR1 . Noticeably, p-STAT3 levels were increased in TNFR1 singleknockout animals, a phenomenon which was not observed in Nemo Dhepa /TNFR1 À / À livers.
Hepatocarcinogenesis in Nemo
Dhepa mice is diminished by blocking TNFR1. Ablation of IKKg/Nemo in liver parenchymal cells triggers spontaneous HCC development. 8 As TNFR1 and TRAIL deletion differentially affected Nemo Dhepa -dependent progression of liver injury, we 
/TNFR1
À / À were subjected to immunoblotting using antibodies against p-STAT3, and using total STAT3 and b-actin as loading controls. (f) The same samples were subjected to immunoblotting using antibodies against p-JNK and p-JunD using b-actin as loading control TNFR1 in chronic liver injury FJ Cubero et al
/TRAIL
À / À livers showed signs of steatosis, with increased lipid deposition that was not evident in Nemo Dhepa /TNFR1
À / À mice. The endothelial cell marker CD34 has been used as a clinical tool in the diagnosis of well-differentiated HCC. 16 
CD34 staining of 52-week-old Nemo
Dhepa and Nemo Dhepa /TRAIL À / À livers revealed a strongly preserved reticulum network within a tumor, which is surrounded by individual tumor cells in a monolayered trabecular pattern, whereas in 1-year-old liver sections of Nemo Dhepa /TNFR1 À / À mice, only a low percentage of CD34-positive cells was detected (Figure 5d ).
Next, we tested fibrosis progression in 1-year-old livers. As shown at earlier time points (see Figure 2) , ablation of TNFR1-but not of TRAIL -also reduced advanced liver fibrosis in 52-week-old Nemo Dhepa mice as demonstrated by quantification of Sirius red-positive areas (Figure 5e ). Our earlier results demonstrated that Nemo deficiency triggers hepatitis associated with the proliferation of CK19-positive cells, which mostly represent liver oval stem cells (Figure 5f ). Interestingly, the numbers of CK19-positive cells in the Nemo Dhepa /TNFR1
À / À liver were significantly reduced compared with Nemo Dhepa livers. Thus, Nemo Dhepa /TNFR1 mice show reduced overall liver damage and disease (Figures 6d and e) . Taking together, these results support the important role of TNFR1 for the progression of chronic liver injury.
Deletion of TNFR1 in hematopoietic cells promotes acute and chronic liver injuries in vivo. As the deletion of TNFR1 in Nemo Dhepa /TRAIL À / À mice highlights its importance for the progression of chronic liver injury, we next aimed to identify the cell type responsible for this effect. Besides hepatocytes, TNFR1 is expressed in most tissues including liver-infiltrating myeloid cells. To test the relevance of bone-marrow-derived cells, we performed bone marrow transplantation (BMT) experiments in 4-6-week-old mice (Figure 7a ). TNFR1 À / À bone marrow was transplanted into Nemo Dhepa animals (TNFR1
following lethal irradiation. WT mice transplanted with WT bone marrow (WT-WT) and TNFR1
À / À mice transplanted with TNFR1 in order to achieve complete replenishment of the Kupffercell population after BMT, we killed the mice, 4 or 48 weeks later, to analyze the contribution of TNFR1 in immune cells to the progression of liver disease (Figure 7a ). Chimerism in the liver was confirmed using PCR, which demonstrated successful reconstitution (Figure 7b ). In the acute situation, Nemo Dhepa livers 4 weeks after TNFR1 À / À bone marrow (TNFR1 À / À -Nemo Dhepa ) elicited the presence of immune infiltration, fat deposition, aberrant mitosis and cell death (Figure 7c ). This was associated with elevated levels of serum ALT (Figure 7d) . Conversely, reconstitution of Nemo Dhepa mice with WT bone marrow (WT-Nemo Dhepa ) resulted in no significant histological or serological difference compared with non-reconstituted Nemo Dhepa mice (Figure 7c) . Reconstitution of double knockouts with WT (WT-Nemo
À / À ) bone marrow had no significant effect compared with the non-reconstituted doubleknockout mice. These livers were characterized by mild infiltration, steatosis and cell death (Figure 7c) .
Finally, we examined the influence of BMT derived from WT-and TNFR1 À / À animals on the progression of Nemo Dhepa -dependent liver injury. We killed chimeric mice 1 year after BMT and evaluated the markers of liver injury and tumorigenesis (Supplementary Figures 6A-C) . As observed at the acute time points, Nemo Dhepa livers reconstituted with TNFR1 À / À bone marrow exhibited strong infiltration, macroand microsteatosis, and massive hepatitis accompanied by increased levels of alkaline phosphatase (AP) and augmented number of nodules 40.5 cm compared with the other BMT controls included. Altogether, these data suggest that bonemarrow-derived TNFR1 is involved in determining the degree of Nemo Dhepa -dependent liver injury.
Discussion
In the present study, we demonstrate that the death receptor TNFR1 is crucial in the interplay with IKKg/Nemo to drive apoptotic cell death of hepatocytes during chronic liver injury. Its cognate ligand TNF is a pleiotropic cytokine produced mainly by KC, NK cells, sinusoidal endothelial cells and hepatic stellate cells, which critically regulate inflammation, cellular injury, cell death/apoptosis and wound healing. Ligand binding of TNF with TNFR1 triggers formation of the IKK complex and transcription of NF-kB-dependent antiapoptotic genes. In the absence of the regulatory subunit IKKg/Nemo, the IKK complex cannot be activated and the canonical NF-kB signaling pathway is blocked, which triggers the Casp8-dependent cell death. 18, 19 This is corroborated by the fact that livers of Nemo Dhepa mice exhibit spontaneously elevated TNF and TNFR1 levels and therefore show increased hepatocyte apoptosis. 13, 20 The impact of IKKg/ Nemo on liver injury is not only relevant in experimental mouse models but also in human disease, as patients with HCC frequently show mutations in the IKKg/Nemo locus. 21 These findings strongly suggest that results in the IKKg/Nemo mouse model are useful for the translation of the bench work into clinical studies.
Our results indicate that elevated TNF levels found in Nemo Dhepa mice are essential in increasing Casp8 activity and subsequent apoptosis, thereby determining the severe spontaneous phenotype of Nemo Dhepa livers. Consequently, Nemo-deficient hepatocytes are more sensitive to TNF and TNF-inducing stimuli such as LPS. 6, 7, 18 In the present study, we demonstrated that the hypersensitivity of Nemo-deficient hepatocytes towards pro-apoptotic stimulation can be at least partially rescued by genetic TNFR1 inactivation. However, blocking Casp8 in Nemo Dhepa hepatocytes completely protected from receptor-mediated apoptosis, 9 suggesting that TNFR1 in chronic liver injury FJ Cubero et al Figure 6 Deletion of TNFR1 signaling in Nemo 13 Therefore, our initial hypothesis was that stable deletion of TRAIL in Nemo Dhepa mice would cause a significant improvement of chronic liver injury. Unexpectedly, disease activity in a genetic approach using Nemo Dhepa /TRAIL À / À double-knockout mice was not ameliorated. Thus, TRAIL-mediated signals are not dominant to determine chronic disease progression in Nemo Dhepa livers. However, they become essential to drive the death of Nemo-deficient cells in scenarios of acute but transient injury as reported, for example, after Concanavalin A treatment. 13 To further validate our findings, we generated
triple-knockout mice. These animals exhibited the same milder phenotype as Nemo Dhepa /TNFR1 À / À mice, supporting our findings that TNFR1 but not TRAIL is essential to determine chronic injury in Nemo Dhepa livers. Higher pro-inflammatory cytokine levels in Nemo Dhepa mice indicate that they are critically involved in the progression of chronic liver injury. In order to better understand the mechanisms ameliorating liver injury in Nemo Dhepa / TNFR1
À / À mice, we performed differential gene-expression profiling from Nemo Dhepa /TNFR1 À / À versus Nemo Dhepa liver tissue. Interestingly, this analysis revealed that besides others, especially pro-inflammatory cytokines were reduced in Nemo Dhepa /TNFR1 À / À livers. In fact, hepatocyte death activates KC to express cytokines such as TNF and IL-6. 22 In agreement with earlier studies, 23 levels of TNF are downregulated after the deletion of TNFR1, which might contribute to reduced activation and recruitment of immune cells found in Nemo Dhepa /TNFR1 À / À mice. IL-6 is a multifunctional cytokine largely responsible for the acute-phase response that exerts hepatoprotective effects. 24, 25 We reasoned that IL-6 levels are increased in Nemo Dhepa mice to counteract hepatocyte damage by inducing hepatic expression of liver-protective proteins such as SAA2. 25, 26 In line with this hypothesis, reduced activation of the IL-6/STAT3/SAA2 cascade as found in Nemo
Dhepa

/TNFR1
À / À mice would be associated with the less-severe liver damage in these animals.
In this context, our data clearly hint at c-Jun N-terminal kinases (JNK) as important downstream mediators of chronic liver injury in Nemo Dhepa mice. JNK and JunD activations are induced in Nemo Dhepa and Nemo Dhepa /TRAIL livers, whereas it is inhibited in Nemo Dhepa mice lacking TNFR1. Transient and modest JNK activation by TNF is associated with cellular survival, whereas prolonged and robust JNK activation contributes to hepatocyte cell death. 27, 28 Transient activation of JNK could be protective, whereas chronic phosphorylation might be pro-apoptotic and thus induce liver damage. Hence, it will be interesting to better define the relevance of JNK for Nemo Dhepa -dependent liver injury.
Ablation of TNFR1 in Nemo
Dhepa mice reduced chronic hepatitis characterized by the destruction of liver cells and the persistence of inflammatory cells. Increased apoptosis in Nemo Dhepa livers triggers compensatory proliferation of hepatocytes. 8, 29 As a consequence, the deletion of TNFR1 decreased cell-death-associated compensatory proliferation and reduced cell cycle activation. Increased chronic liver damage and compensatory proliferation trigger liver fibrosis in Nemo Dhepa mice. TNFR1 À / À mice fed with MCD diet, an experimental model of NASH, display less KC activation and decreased fibrosis, associated with reduced collagen deposition. Thus, a role for TNF via TNFR1 in liver fibrosis has been suggested. 30, 31 TNFR1 also contributes to spontaneous liver injury, inflammation and fibrosis in hepatocyte-specific TAK1 knockout mice. 32 Previous publications 33 suggest that LPS via the activation of TLR4 and the downregulation of BAMBI is profibrogenic, which could also explain the reduced fibrogenesis in Nemo Dhepa /TNFR1 livers.
Chronic inflammation increases the risk of cancer development, a characteristic of Nemo Dhepa mice. 8 High levels of TNF in these mice contribute to maintain steatohepatitis and subsequently to develop HCC. Tumor progression has been linked to oval-cell proliferation commonly seen in the preneoplastic stages of liver carcinogenesis and often accompanied by an inflammatory response. 34 Nemo Dhepa mice show strong activation of the oval-cell compartment to compensate hepatocyte death. After TNFR1 deletion, the oval-cell response as well as the tumor growth in Nemo
Dhepa
/TNFR1
À / À livers are decreased. Our observations are in agreement with current literature [34] [35] [36] [37] strongly suggesting that TNFR1 deficiency is crucial for tumor promotion. A recent paper suggests that TNFR1 ablation, in contrast to IL-6 and MyD88, has no significant effect on hepatocarcinogenesis in the DEN model. 25 However, the same group showed that TNFR1 ablation almost completely abolished obesityenhanced HCC development. 38 Altogether, these data suggest that TNFR1 may especially have a crucial role in NASH/inflammation-triggered tumorigenesis by exerting an essential effect on liver injury.
From our data we hypothesized that in Nemo Dhepa livers, infiltrating hematopoietic cells are an essential source of TNF, whereas Nemo-deficient hepatocytes are the main TNFR1-expressing target cells. In order to better support this hypothesis, we generated chimeras with TNFR1 À / À bone marrow in Nemo Dhepa and Nemo Dhepa /TNFR1 À / À recipients including their respective controls. Acute and long-term experiments demonstrated that the deletion of TNFR1 in infiltrating immune cells promoted acute and chronic liver diseases in Nemo Dhepa mice. It is tempting to speculate that higher phosphorylation levels of STAT3 observed in TNFR1 À / À mice might in part be linked to this finding, as it is neutralised in Nemo Dhepa /TNFR1 À / À mice. Our current model derived from these data is illustrated in Figure 8 . In agreement with our previous publications, 8 Nemo Dhepa mice show high levels of pro-inflammatory cytokines (TNF, IL-6) that increases liver injury by activating TNFR1-dependent apoptosis in hepatocytes.
Moreover, our data suggest that TNFR1 deficiency in immune cells deteriorates Nemo Dhepa -induced liver injury. Consequently, these findings have major clinical implications. Targeting TNF and TNF receptor for disease intervention is already established for autoimmune and inflammatory disorders. 39 Earlier clinical studies evaluated the promising use of anti-TNF antibodies in alcoholic steatohepatitis (ASH). 40 However, subsequent clinical trials with higher anti-TNF concentrations failed to have a positive effect in these patients and the studies were terminated. 41 Indeed, a primary challenge will be to achieve specificity and efficacy without having any undesirable effects. Here, cell-specific targeting could be a promising approach to improve the clinical outcome of TNF-driven diseases. In summary, modulating the function of IKKg/Nemo in mice and humans has been linked to chronic liver injury and HCC development. In the present study, we show that deletion of TNFR1 in hepatocytes is protective, whereas TNFR1 inactivation in bone-marrow-derived cells might be harmful in the context of Nemo Dhepa -dependent liver injury. Thus, our data suggest that the cell-specific role of TNF-dependent signaling should be considered to optimise future therapeutic strategies.
Materials and Methods
Housing and generation of knockout mice. Animals were maintained in the animal facility of the University Hospital RWTH Aachen according to the German legal requirements. Hepatocyte-specific IKKg/Nemo mice were generated by crossing loxP site-flanked (floxed [f]) Nemo gene (Nemo f/f ) with alfp-cre transgenic animals as described before. 13 
À / À were also used as controls. Genotypes were confirmed via PCR specific for the respective alleles using DNA from tail biopsies. Progression of liver disease was investigated in male mice between 8-9 weeks and 52-54 weeks of age. Liver injury experiments were performed on mice between 8 and 9 weeks of age. Serum AST and ALT were measured by the standard procedures in the Institute of Clinical Chemistry, University Hospital, RWTH-Aachen.
TUNEL assay, BrdU assay and caspase-3/8 assay. TUNEL test and BrdU staining were performed by the standard procedures. Caspase-3 and Caspase-8 were measured by using Ac-DEVD-AFC and Ac-IETD-AFC as fluorescent substrates (Biomol GmbH, Hamburg, Germany). Frozen livers were homogenized in ice-cold lysis buffer (1 mol/l HEPES, 10% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate, 0.5 mol/l EDTA, 1 mol/l dithiothreitol and 0.1 mol/l Pefabloc), and protein lysates were incubated with either Ac-DEVD-AFC or Ac-IETD-AFC at 37 1C. After 1 h, the kinetics of enzymatic activity was measured in a luminescence spectrophotometer at a l excitation of 390 nm and l emission of 510 nm.
Bone marrow transplantation. We transferred bone marrow of TNFR1 À / À or WT mice (n ¼ 7-8 mice per group) into 4-6-week-old recipients (isogenic on a C57BL/6J background) after ablative g-irradiation, as described previously.
42 After 8-10 weeks and 1 year, mice were killed, and liver and serum samples were collected.
Microarray analysis. Affymetrix Microarray data have been deposited with the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE3316. RNA was isolated from mouse livers using TRIzol reagent and purified with the RNeasy Mini Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer's instructions. Concentrations and purity of RNA samples were determined on a NanoDrop ND-1000 spectrophotometer (Isogen, Maarssen, The Netherlands). RNA integrity was checked on an Agilent 2100 bioanalyzer (Agilent Technologies, Amsterdam, The Netherlands) with 6000 Nano Chips. RNA samples from three mice per experimental group were used for microarray analysis. Samples were hybridized on the Affymetrix GeneChip Mouse Genome 430 2.0 arrays in the microarray core laboratory of the Nutrigenomics Consortium at Wageningen University, The Netherlands. Hybridization, washing and scanning of the arrays were performed according to standard Affymetrix protocols. Array images were processed using packages from the Bioconductor project. 43 Probe sets were redefined according to Dai. 44 Probes were assigned to unique gene identifiers, in this case Entrez IDs. Arrays were normalized by quantile normalization and expression estimates were calculated using GC robust multiarray average background adjustment. 45 Differentially expressed genes were identified using linear models with application of moderated t-statistics that implement empirical Bayes regularization of standard errors. 46 Genes that satisfied the criteria of a P-value of less than 0.01 and fold change greater than 2 were considered to be expressed differentially. Detailed descriptions of the applied methods are available on request.
Primary hepatocyte culture. Primary hepatocytes were prepared by perfusing the portal vein of the liver with EBSS containing 100 mM EGTA (pH 8. /well) were cultured in Dulbecco's modified medium with 10% FBS, 2 mM L-glutamine and antibiotics on six-well plates with pre-coated and PBS-washed 2.5 mg/ml type I collagen.
Immunoblot and protein analyses. Protein extracts were electrophoresed and then blotted following standard procedures. Blots were incubated with primary antibodies for cleaved Caspase 3 (Cell Signaling Technology, New England Biolabs GmbH, Frankfurt, Germany), phospho-JNK (Cell Signaling Technology), Cyclin A (Santa Cruz Biotechnology, Heidelberg, Germany), p21 (Santa Cruz Biotechnology), PCNA (Cell Signaling Technology) phospho JunD (Ser100) (Cell Signaling Technology), Collagen 1 (Monosan, Uden, The Netherlands), a-SMA (Cymbos Biotech, Hofheim, Germany), p-STAT3 (Cell Signaling Technology) and TNFR1 (Santa Cruz Biotechnology). As a loading control, we used total Caspase 3 (Cell Signaling Technology), total STAT3 (Santa Cruz Biotechnology) and b-actin antibody (Sigma-Aldrich GmbH, Munich, Germany). We used anti-rabbit IgG-HRP-linked (Cell Signaling Biotechnology) and anti-mouse IgG-HRP-linked (Santa Cruz Biotechnology) as secondary antibodies. Analysis of intrahepatic IL-6 was performed in duplicate using a murine ELISA (BD Biosciences, Heidelberg, Germany).
Quantitative real-time PCR. Total RNA was purified from liver tissues using Trizol reagent (Invitrogen, Karlsruhe, Germany). Total RNA (1 mg) was used to synthesize cDNA using SuperScript first-Stand Synthesis System (Invitrogen) and was resuspended in 100 ml of H 2 O. Quantitative real time PCR was performed using SYBR Green Reagent (Invitrogen) in 7300 Real Time PCR system (Applied Biosystem, Darmstadt, Germany). GAPDH expression was used to normalize gene expression, which is represented as times versus WT basal expression. Primer sequences can be provided upon request.
Histological, immunofluorescence and immunohistochemical analyses. Livers from mice were harvested and, after fixation with 4% PFA, were embedded in paraffin for further histological evaluation. H&E, Oil-Red-O and Sirius Red staining were performed on liver sections. For immunofluorescence analysis, liver cryosections of 5 mm were stained with rat anti-mouse CD11b, rat anti-mouse F4/80, rat anti-mouse Ly6G and rat anti-mouse Ki-67 (all from BD Biosciences). Slides were fixed in 4% PFA at room temperature. Secondary antibody conjugated with FITC, Cy3 (Jackson Immunoresearch, West Grove, PA, USA) was used to obtain green and red fluorescence signals. Mounting solution containing DAPI (Vector Laboratories, Burlingame, CA, USA) was used to counterstain the nuclei of hepatocytes. Paraffin tissue sections from the mouse liver were deparaffinized and rehydrated. After antigen retrieval, sections were incubated overnight at 4 1C with primary biotin-anti-mouse CD45 (clone 30E11; Pharmingen, Heidelberg, Germany) diluted in TBS buffer containing 1% BSA and 0.1% Tween 20. Thereafter, the sections were incubated with streptavidin ABC-alkaline phosphatase (Vector Laboratories) and color was developed with Vector red staining kit (Vector Laboratories) followed by hematoxylin counterstaining.
Flow cytometry analysis. Hepatocytes were stained with Annexin V-FITC (BD Biosciences). Immune cells from whole liver were isolated and stained with fluorochrome-conjugated antibodies (CD4-PE, CD8-FITC, CD45-APC-Cy7, CD11b-PE, Ly6G-FITC and F4/80 Biotin) (BD Biosciences). All samples were acquired by flow cytometry (FACS Canto II; BD Biosciences) and analyzed using the Flowjo software (Ashland, OR, USA).
Statistical analysis. Data are expressed as the mean ± S.D. Statistical significance was determined via two-way analysis of variance followed by Student's t-test. Figure 8 Proposed model for the activation of TNFR1-signaling cascade. In Nemo Dhepa mice hepatocyte apoptosis promotes an inflammatory environment that activates Kupffer cells, which release cytokines such as TNF triggering compensatory proliferation, hepatitis and tumor development. In the absence of TNFR1 in hepatocytes, acute and chronic liver injuries are ameliorated. Nemo
Dhepa chimeric mice reconstituted with TNFR1 À / À bone marrow show that TNFR1 activation is crucial in hepatocytes but also in bone-marrow-derived cells. Immune cells lacking TNFR1 promote the development of liver injury in Nemo Dhepa mice
